Antioxidant supplementation in sepsis and systemic inflammatory response syndrome

Details

Serval ID
serval:BIB_6406FE961C75
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
Antioxidant supplementation in sepsis and systemic inflammatory response syndrome
Journal
Critical Care Medicine
Author(s)
Berger  M. M., Chiolero  R. L.
ISSN
0090-3493 (Print)
Publication state
Published
Issued date
09/2007
Volume
35
Number
9 Suppl
Pages
S584-90
Notes
Journal Article --- Old month value: Sep
Abstract
OBJECTIVE: Summarize the current knowledge about oxidative stress-related organ dysfunction in inflammatory and septic conditions, and its potential prevention and treatment by antioxidants in critically ill patients, focusing on naturally occurring antioxidants and clinical trials. STUDY SELECTION: PubMed, MEDLINE, and personal database search. SYNTHESIS: Plasma concentrations of antioxidant micronutrients are depressed during critical illness and especially during sepsis. The causes of these low levels include losses with biological fluids, low intakes, dilution by resuscitation fluids, as well as systemic inflammatory response syndrome-mediated redistribution of micronutrients from plasma to tissues. Numerous clinical trials have been conducted, many of which have shown beneficial effects of supplementation. Interestingly, among the candidates, glutamine, glutathione, and selenium are linked with the potent glutathione peroxidase enzyme family at some stage of their synthesis and metabolism. CONCLUSIONS: Three antioxidant nutrients have demonstrated clinical benefits and reached level A evidence: a) selenium improves clinical outcome (infections, organ failure); b) glutamine reduces infectious complication in large-sized trials; and c) the association of eicosapentaenoic acid and micronutrients has significant anti-inflammatory effects. Other antioxidants are still on the clinical benchmark level, awaiting well-designed clinical trials.
Pubmed
Web of science
Create date
24/01/2008 17:52
Last modification date
20/08/2019 15:20
Usage data